(Q37411551)

20 August 2017

Prospective case-control study of serum mullerian inhibiting substance and breast cancer risk (English)

1 reference

20 August 2017

0 references

1 reference

8

Louise A Brinton

1 reference

20 August 2017

2

Frank Z Stanczyk

1 reference

20 August 2017

4

Lisa L Kahle

1 reference

20 August 2017

Joanne F Dorgan

1

1 reference

20 August 2017

Brian L Egleston

3

1 reference

20 August 2017

Christiana M Shaw

5

1 reference

20 August 2017

Cynthia S Spittle

6

1 reference

20 August 2017

Andrew K Godwin

7

1 reference

20 August 2017

language of work or name

English

0 references

publication date

9 October 2009

1 reference

Journal of the National Cancer Institute

20 August 2017

1 reference

20 August 2017

101

1 reference

20 August 2017

21

1 reference

20 August 2017

1501-1509

1 reference

Assay reproducibility and within-person variation of Müllerian inhibiting substance

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773186

The Anti-Mullerian hormone and ovarian cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773186

The risk of breast, endometrial and ovarian cancer in users of hormonal preparations

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773186

Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773186

Mullerian inhibiting substance suppresses tumor growth in the C3(1)T antigen transgenic mouse mammary carcinoma model

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773186

Regulation of ovarian function: the role of anti-Müllerian hormone

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773186

Müllerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications

6 September 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773186

6 September 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773186

Mullerian inhibiting substance regulates NFkappaB signaling and growth of mammary epithelial cells in vivo

2 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773186

Menstrual factors and breast cancer risk.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773186

Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773186

Aromatase and breast cancer susceptibility

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773186

Ovarian androgen production in postmenopausal women

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773186

Müllerian-inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773186

Serum anti-Mullerian hormone throughout the human menstrual cycle.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773186

Anti-Müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773186

Pilot study investigating the age-related decline in ovarian function of regularly menstruating normal women

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773186

High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773186

Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transition

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773186

Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773186

Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773186

Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773186

Antimüllerian hormone serum levels: a putative marker for ovarian aging

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773186

Relationship between serum müllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773186

A critical evaluation of simple methods for the estimation of free testosterone in serum.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773186

Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773186

Mullerian inhibiting substance in humans: normal levels from infancy to adulthood.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773186

Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773186

Serum testosterone concentrations in women throughout the menstrual cycle and following HCG administration

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773186

Serum müllerian-inhibiting substance levels during normal menstrual cycles

2 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19820206

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Mullerian inhibiting substance inhibits breast cancer cell growth through an NFkappa B-mediated pathway

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19820206

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Secretion of androgens and estrogens by normal and neoplastic ovaries in postmenopausal women

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19820206

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/JNCI/DJP331

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

19820206

1 reference